Navigation Links
Texcel Highlights Medical Device Development & Manufacturing Solutions at MD&M West, booth 314
Date:2/4/2009

EAST LONGMEADOW, Mass., Feb. 4 /PRNewswire/ -- Texcel's custom medical device development and manufacturing solutions helps companies around the world accelerate the commercialization of their surgical, interventional, and implantable medical device technologies. Texcel will highlight its full array of services and technologies at the MD&M West Expo, February 10-12, 2009, in exposition booth # 314.

Texcel provides the manufacturing infrastructure and expertise for a wide range of product applications -- from endoscopic surgical instrumentation and spinal/orthopedic implants to total artificial hearts and neurostimulators.

Texcel's specialized services and full medical device solutions include device design, development history file management, quality and regulatory assistance, process validation, along with general manufacturing, electronic testing, laser welding, and clean-room processing for a wide range of product applications.

Texcel, with more than 20 years of experience assisting companies execute increasingly sophisticated designs through reliable manufacturing, has particular expertise in five key areas:

  • Orthopedics, including products ranging from metal bone fastening devices to novel new materials;
  • Cardiac Assist, with expertise helping industry pioneers assemble and produce many types of cardiac assist devices;
  • Active Implantables, including a wide range of metal and non-metal biocompatible materials as well as dynamic mechanical and electrical features;
  • Combination Products, combining strong internal development and manufacturing capabilities with partners specializing in pharmaceuticals.
  • General Instrumentation, including a wide array of interventional products from durable medical equipment components to disposable catheter devices, and a full range of materials and assembly methods.

"By combining our comprehensive, highly integrated suite of capabilities and state of the art production facility into a single, seamless solution, we manage all the concerns of development and manufacturing process for our clients. We thus empower our clients to focus other priorities, such as developing new markets and therapies based on their proprietary technologies," said Keith Checca, Director of Business Development, Texcel, (www.texcelmedical.com).

The company is staffed with over fifty (50) talented, experienced, and passionate medical device industry employees within an ISO 13485 and ISO 9001 environment.

Based in East Longmeadow, Massachusetts, Texcel works with companies around the world.

For more information, visit Texcel at MD&M West 2009 in booth # 314; online visit www.texcelmedical.com, or call 413-525-5700.


'/>"/>
SOURCE Texcel
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
2. Highlights of Economic and Business Growth in the Tampa Bay Region
3. Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
4. Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
5. Highlights of Economic and Business Growth in the Tampa Bay Region
6. Highlights of Economic and Business Growth in the Tampa Bay Region
7. Oncothyreon highlights corporate and clinical objectives for 2008
8. CyberKnife Users Meeting Highlights Major Clinical Data Milestones and Emerging Trends
9. National Nanotechnology Initiative releases its fiscal year 2009 budget and highlights
10. MEDEA+ Noblanc award highlights improvements in microelectronics
11. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Austin, TX (PRWEB) , ... October 11, 2017 ... ... in August compared the implantation and pregnancy rates in frozen and fresh ... the contribution of progesterone and maternal age to IVF success. , After comparing ...
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
(Date:10/10/2017)... research firm Parks Associates announced today that Tom Kerber ... Annual Meeting , October 11 in Scottsdale, Arizona . ... how smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and the ...
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon Program Committee ... honoring scientists who have made outstanding contributions to analytical chemistry and applied ... the world’s leading conference and exposition for laboratory science, which will be held ...
Breaking Biology Technology:
(Date:8/23/2017)...  The general public,s help is being enlisted in what,s thought to ... and on the human body –and are believed to affect health.  ... The Microbiome Immunity Project is the largest ... the gut. The project's goal is to help advance scientific knowledge of ... ...
(Date:7/20/2017)... -- Delta (NYSE: DAL ) customers now can use fingerprints ... Washington National Airport (DCA). ... Delta launches biometrics to board aircraft at Reagan Washington National ... Delta,s biometric boarding pass experience that launched ... into the boarding process to allow eligible Delta SkyMiles Members who are ...
(Date:6/23/2017)... and ITHACA, N.Y. , ... and Cornell University, a leader in dairy research, today ... bioinformatics designed to help reduce the chances that the ... the onset of this dairy project, Cornell University has ... for Sequencing the Food Supply Chain, a food safety ...
Breaking Biology News(10 mins):